HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit an electronic Letter to the Editor about this paper Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via ISI Web of Science (6) Citing Articles via Google Scholar Google Scholar Articles by Choi, M. H. Articles by Chung, B. C. Search for Related Content PubMed PubMed Citation Articles by Choi, M. H. Articles by Chung, B. C. Related Collections Cancer Diagnostics (since 2002) Endocrinology and Metabolism Automation and Analytical Techniques

Rapid HPLC-Electrospray Tandem Mass Spectrometric Assay for Urinary Testosterone and Dihydrotestosterone Glucuronides from Patients with Benign Prostate Hyperplasia

¹ Bioanalysis & Biotransformation Research Center, KIST, Seoul 130-650, Korea;
² -Division of Food Investigation, Korea Advanced Food Research Institute, Seoul 137-060, Korea;

^aaddress correspondence to this author at: Bioanalysis & Biotransformation Research Center, Korea Institute of Science and Technology, PO Box 131, Cheongryang, Seoul 130-650, Korea; fax 82-2-958-5059, e-mail bcc0319@kist.re.kr

The first 300 words of the full text of this article appear below.

The development of benign prostatic hyperplasia (BPH) is dependent on androgens, primarily dihydrotestosterone (DHT) (1). To estimate the activity of 5-reductase, which catalyzes the conversion of testosterone to DHT, testosterone and DHT have been quantified in biological samples (2)(3)(4). Because of their lipophilic properties, they are usually found in the conjugated form, i.e., linked to a hydrophilic sulfuric moiety or ß-glucuronic acid, which are excreted mainly (>95%) in human urine. Despite reports of a close association between BPH and testosterone and DHT (1)(2)(3)(4), to our knowledge, there is no published simultaneous quantitative data for these metabolites as their glucuronides in the urine of patients with BPH.

The major problem associated with quantification of total steroids is incomplete hydrolysis, attributable mainly to the matrix effects of urine on the efficiency of enzymatic hydrolysis, which reduces the reproducibility of the assay (5)(6). Given that it is often necessary to analyze many samples in a short time with good sensitivity and reproducibility, system throughput is a critical issue for many clinical mass spectrometry (MS) groups. In continuation of studies of steroid profiles in diseases related to steroid enzymes (7)(8), we here demonstrate a sensitive and precise HPLC-tandem MS method for quantification of testosterone and DHT glucuronides by use of a three-column, two-switching valve system and the presence of the indicative biomarker in urine samples from BPH patients.

We obtained 24-h urine samples from 27 patients [mean (SD) age, 46 (5) years; range, 38–55 years] treated at Yonsei Medical Center (Seoul, Korea), including 19 men with BPH and 8 healthy men who underwent digital rectal examination and a prostate-specific antigen blood test. The latter were matched with the BPH . . . [Full Text of this Article]